RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
PTC Therapeutics Stock

PTC Therapeutics Equity 2024

PTC Therapeutics Equity

-818.55 M USD

Ticker

PTCT

ISIN

US69366J2006

WKN

A1W0MW

In 2024, PTC Therapeutics's equity was -818.55 M USD, a 135.83% increase from the -347.1 M USD equity in the previous year.

PTC Therapeutics Aktienanalyse

What does PTC Therapeutics do?

PTC Therapeutics Inc. is a biopharmaceutical company based in South Plainfield, New Jersey. The company was founded in 1998 and focuses on the research and development of drugs for the treatment of rare diseases. The company has two main divisions: product research and development, and science and innovation. Its product range includes several drugs for the treatment of rare diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and cystic fibrosis. One of its key products is Translarna, the first RNA-targeted drug approved for the treatment of Duchenne muscular dystrophy. Another product is Evrysdi, approved for the treatment of spinal muscular atrophy. PTC Therapeutics also has a pipeline of drugs being tested in clinical trials for various rare diseases. The company is committed to promoting innovation and has partnerships with academic institutions and other companies to explore and develop new therapies. Overall, PTC Therapeutics aims to improve the lives of patients with rare diseases through innovative treatments. PTC Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing PTC Therapeutics's Equity

PTC Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding PTC Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating PTC Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

PTC Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in PTC Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about PTC Therapeutics stock

What is the equity of PTC Therapeutics this year?

PTC Therapeutics has equity of -818.55 M USD this year.

What was the equity of PTC Therapeutics compared to the previous year?

The equity of PTC Therapeutics has increased/decreased by 135.83% increased compared to the previous year.

What impact does a high equity have on investors of PTC Therapeutics?

A high equity is advantageous for investors of PTC Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of PTC Therapeutics?

A low equity can be a risk for investors of PTC Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of PTC Therapeutics affect the company?

An increase in equity of PTC Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of PTC Therapeutics affect the company?

A reduction in equity of PTC Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of PTC Therapeutics?

Some factors that can affect the equity of PTC Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of PTC Therapeutics so important for investors?

The equity of PTC Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can PTC Therapeutics take to change the equity?

To change equity, PTC Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does PTC Therapeutics pay?

Over the past 12 months, PTC Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PTC Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of PTC Therapeutics?

The current dividend yield of PTC Therapeutics is .

When does PTC Therapeutics pay dividends?

PTC Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PTC Therapeutics?

PTC Therapeutics paid dividends every year for the past 0 years.

What is the dividend of PTC Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is PTC Therapeutics located?

PTC Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von PTC Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PTC Therapeutics from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did PTC Therapeutics pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of PTC Therapeutics in the year 2023?

In the year 2023, PTC Therapeutics distributed 0 USD as dividends.

In which currency does PTC Therapeutics pay out the dividend?

The dividends of PTC Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von PTC Therapeutics

Our stock analysis for PTC Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PTC Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.